^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GB104

    i
    Associations

    News

    Trials
    Company:
    GI Biome
    Drug class:
    Immunostimulant, Microbiome modulator
    Related drugs:
    Associations

    News

    Trials
    2ms
    GB-X01-101: Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer (clinicaltrials.gov)
    P1, N=9, Completed, GI Biome, Inc. | Recruiting --> Completed | N=18 --> 9
    Trial completion • Enrollment change
    |
    GB104
    almost2years
    Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer (clinicaltrials.gov)
    P1, N=18, Recruiting, GI Biome, Inc.
    New P1 trial
    |
    GB104